Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory Molecules
Megan M. Suhoski, Tatiana N. Golovina, Nicole A. Aqui et al. · Molecular Therapy · 2007
To facilitate the therapeutic application of antigen-presenting cells (APCs), we have developed a cell-based artificial APC (aAPC) system by engineering K562 cells with lentiviruses to direct the stable expression and secretion of a variety of co-stimulatory molecules and cytokines. Here we report the use of a combinatorial lentiviral gene transfer approach to achieve long-term stable expression of at least seven genes in the K562 parental cell line. Expression of various combinations of genes on the aAPC enables the precise determination of human T-cell activation requirements, such that aAPCs can be tailored for the optimal propagation of T-cell subsets with specific growth requirements and distinct functions. The aAPCs support ex vivo growth and long-term expansion of functional human CD8 T cells without requiring the addition of exogenous cytokines, in contrast to the use of natural APCs. Distinct populations of T cells can be expanded with aAPCs expressing CD137L (4-1BBL) and/or CD80. Finally, the aAPCs provide an efficient platform to expand genetically modified T cells and to maintain CD28 expression on CD8 T cells. Therefore, K562-based aAPCs have therapeutic potential for adoptive immunotherapies and vaccinations.
Cited by 266 works. doi:10.1038/mt.sj.6300134 Open-access PDF
Authors
- Megan M. Suhoski
- Tatiana N. Golovina
- Nicole A. Aqui
- Victoria C Tai
- Angel Varela‐Rohena
- Michael C. Milone
- Richard G. Carroll
- James L. Riley
- Carl H. June
References
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
- Tolerogenic Dendritic Cells
- T-Cell Proliferation Involving the CD28 Pathway Is Associated witH Cyclosporine-Resistant Interleukin 2 Gene Expression
- Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells
- IgG Fc Receptors
- The Duration of Antigenic Stimulation Determines the Fate of Naive and Effector T Cells
- Clinical significance of defective dendritic cell differentiation in cancer.
- Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
- Dendritic cells as therapeutic vaccines against cancer
- Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts